Rayence Co Ltd
KOSDAQ:228850
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Rayence Co Ltd
Operating Income
Rayence Co Ltd
Operating Income Peer Comparison
145720
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Rayence Co Ltd
KOSDAQ:228850
|
Operating Income
₩17.8B
|
CAGR 3-Years
73%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Dentium Co Ltd
KRX:145720
|
Operating Income
₩136B
|
CAGR 3-Years
43%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Operating Income
₩34B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Operating Income
₩96.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Operating Income
₩46.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
53%
|
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
Operating Income
₩255.6B
|
CAGR 3-Years
98%
|
CAGR 5-Years
71%
|
CAGR 10-Years
31%
|
See Also
What is Rayence Co Ltd's Operating Income?
Operating Income
17.8B
KRW
Based on the financial report for Mar 31, 2024, Rayence Co Ltd's Operating Income amounts to 17.8B KRW.
What is Rayence Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
0%
Over the last year, the Operating Income growth was -18%. The average annual Operating Income growth rates for Rayence Co Ltd have been 73% over the past three years .
You don't have any saved screeners yet
